Cowen and Company’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Cowen and Company’s Portfolio AONC Stock Details AONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-65,000	Closed	-$671K	–	703
2023 Q2	$671K	Buy	+65,000	New	+$666K	0.06%	168

Other funds holding AONC

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cowen and Company's AONC Position: Q3 2023 in Review

Cowen and Company sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q3 2023, closing a stake of 65,000 shares — an estimated $671K sold.

Cowen and Company first reported a position in AONC in Q2 2023 and held it in 1 quarter. The position peaked at $671K in Q2 2023. 3 funds tracked by Wall St. Rank hold AONC as of Q3 2023.

Cowen and Company reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Cowen and Company sold 65,000 American Oncology Network, Inc. Class A Common Stock shares in Q3 2023, an estimated $671K.
Cowen and Company first reported a position in American Oncology Network, Inc. Class A Common Stock in Q2 2023 and held it in 1 quarter.
Cowen and Company's American Oncology Network, Inc. Class A Common Stock position peaked at $671K in Q2 2023.
3 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q3 2023.

Based on Cowen and Company's 13F filing for Q3 2023, filed 9 Nov 2023.